Atrys Health SL (ATRY) - Total Assets
Based on the latest financial reports, Atrys Health SL (ATRY) holds total assets worth €494.04 Million EUR (≈ $577.59 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check Atrys Health SL (ATRY) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Atrys Health SL - Total Assets Trend (2012–2025)
This chart illustrates how Atrys Health SL's total assets have evolved over time, based on quarterly financial data. Check Atrys Health SL (ATRY) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Atrys Health SL - Asset Composition Analysis
Current Asset Composition (December 2025)
Atrys Health SL's total assets of €494.04 Million consist of 47.4% current assets and 52.6% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 2.6% |
| Accounts Receivable | €29.46 Million | 6.0% |
| Inventory | €2.24 Million | 0.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €75.63 Million | 15.3% |
| Goodwill | €132.45 Million | 26.8% |
Asset Composition Trend (2012–2025)
This chart illustrates how Atrys Health SL's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Atrys Health SL.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Atrys Health SL's current assets represent 47.4% of total assets in 2025, an increase from 26.0% in 2012.
- Cash Position: Cash and equivalents constituted 2.6% of total assets in 2025, up from 2.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 40.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 26.8% of total assets.
Atrys Health SL Competitors by Total Assets
Key competitors of Atrys Health SL based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392
|
China | CN¥13.76 Billion |
|
Amicus Therapeutics Inc
NASDAQ:FOLD
|
USA | $949.87 Million |
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294
|
China | CN¥8.41 Billion |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197
|
China | CN¥772.57 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653
|
China | CN¥964.85 Million |
|
Jiangsu GDK Biotechnology Co Ltd
SHG:688670
|
China | CN¥1.48 Billion |
Atrys Health SL - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.81 | 0.89 | 1.74 |
| Quick Ratio | 0.80 | 0.88 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-56.46 Million | €-10.61 Million | €15.85 Million |
Atrys Health SL - Advanced Valuation Insights
This section examines the relationship between Atrys Health SL's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.33 |
| Latest Market Cap to Assets Ratio | 0.41 |
| Asset Growth Rate (YoY) | -15.4% |
| Total Assets | €494.04 Million |
| Market Capitalization | $202.32 Million USD |
Valuation Analysis
Below Book Valuation: The market values Atrys Health SL's assets below their book value (0.41x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Atrys Health SL's assets decreased by 15.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Atrys Health SL (2012–2025)
The table below shows the annual total assets of Atrys Health SL from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €494.04 Million ≈ $577.59 Million |
-15.43% |
| 2024-12-31 | €584.19 Million ≈ $682.98 Million |
-7.12% |
| 2023-12-31 | €629.00 Million ≈ $735.37 Million |
-10.82% |
| 2022-12-31 | €705.28 Million ≈ $824.55 Million |
+24.69% |
| 2021-12-31 | €565.63 Million ≈ $661.28 Million |
+221.79% |
| 2020-12-31 | €175.78 Million ≈ $205.50 Million |
+99.65% |
| 2019-12-31 | €88.04 Million ≈ $102.93 Million |
+63.97% |
| 2018-12-31 | €53.69 Million ≈ $62.77 Million |
+33.58% |
| 2017-12-31 | €40.20 Million ≈ $46.99 Million |
+31.50% |
| 2016-12-31 | €30.57 Million ≈ $35.74 Million |
+17.14% |
| 2015-12-31 | €26.10 Million ≈ $30.51 Million |
+33.62% |
| 2014-12-31 | €19.53 Million ≈ $22.83 Million |
+3.49% |
| 2013-12-31 | €18.87 Million ≈ $22.06 Million |
+3.16% |
| 2012-12-31 | €18.29 Million ≈ $21.39 Million |
-- |
About Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of r… Read more